UBE2CP3: A Potential Drug Target and Biomarker (G100129983)
UBE2CP3: A Potential Drug Target and Biomarker
Uncovering new drug targets and biomarkers is a critical aspect of drug development. It is the process of identifying potential therapeutic targets and biomarkers that can be used to monitor the effectiveness of a drug. In this article, we will discuss UBE2CP3, a protein that has been identified as a potential drug target and biomarker.
The UBE2CP3 gene
UBE2CP3 is a gene that encodes a protein located in the endoplasmic reticulum (ER) of cells. The ER is a network of organelles that transports and modifies proteins before they are released into the cytoplasm. UBE2CP3 is a 21-kDa protein that is involved in the transport of a variety of proteins, including nuclear proteins and intracellular proteins.
Expression of UBE2CP3
UBE2CP3 is highly expressed in most tissues and cells, including the brain, pancreas, and gastrointestinal tract. It is also expressed in various cell types, including blood cells, muscle cells, and epithelial cells. UBE2CP3 is primarily expressed in the endoplasmic reticulum and is involved in the transport of proteins to the ER.
In addition to its expression in the ER, UBE2CP3 is also expressed in the cytoplasm, which suggests that it may be involved in the delivery of proteins into the cytoplasm. This is further supported by the fact that UBE2CP3 is known to interact with the protein transmembrane protease (TMP) 4, which is involved in the delivery of proteins across the endoplasmic reticulum.
Potential drug target
UBE2CP3 has been identified as a potential drug target due to its involvement in the transport of proteins to the ER. Many drugs work by modulating the activity of proteins, either by interacting with them directly or by inhibiting the interactions between them. By targeting UBE2CP3, drugs may be able to interfere with the delivery of proteins to the ER, which could lead to a variety of potential therapeutic effects.
One potential mechanism by which UBE2CP3 may be targeted by drugs is by inhibiting its interaction with TMP4. As mentioned earlier, UBE2CP3 interacts with TMP4 and is involved in the delivery of proteins to the ER. By inhibiting this interaction, drugs may be able to prevent the delivery of proteins to the ER, which could lead to a variety of potential therapeutic effects.
Another potential mechanism by which UBE2CP3 may be targeted by drugs is by modulating its expression levels. UBE2CP3 is highly expressed in most tissues and cells, and it is not known to be regulated by many transcription factors. This suggests that drugs may be able to modify the expression levels of UBE2CP3 to either increase or decrease its levels in certain tissues or cells.
UBE2CP3 has also been identified as a potential biomarker for a variety of diseases. One potential mechanism by which UBE2CP3 may be used as a biomarker is by its role in the transport of proteins to the ER. As mentioned earlier, UBE2CP3 is involved in the delivery of proteins to the ER, and it is possible that alterations in the delivery of proteins to the ER could be associated with a variety of diseases.
For example, UBE2CP3 has been identified as a potential biomarker for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and are often associated with the delivery of proteins to the ER. By targeting UBE2CP3, drugs may be able to interfere with the delivery of these proteins to the ER, which could lead to a variety of potential therapeutic effects.
Another potential use for UBE2CP3 as a biomarker is in the diagnosis of cancer. Many
Protein Name: Ubiquitin Conjugating Enzyme E2 C Pseudogene 3
More Common Targets
A2M | A2MP1 | A4GALT | ABAT | ABCA1 | ABCB1 | ABCB6 | ABCC5 | ABCC9 | ABCF2 | ABCG2 | ABHD11-AS1 | ABHD3 | ABI1 | ABI2 | ACAA1 | ACACA | ACAN | ACE | ACE2 | ACE3P | ACOT8 | ACP5 | ACSF3 | ACTA2-AS1 | ACTBP12 | ACTG1P12 | ACTG1P22 | ACTL10 | ACTN1-DT | ACTR1A | ACTR1B | ACTR2 | ACTR3 | ACVR2B-AS1 | ADA | ADAD2 | ADAL | ADAM1B | ADAM22 | ADAM8 | ADAMTS15 | ADAMTS16 | ADAMTS17 | ADAMTS18 | ADAMTS19 | ADAMTS9-AS2 | ADAMTSL4 | ADCY4 | ADD1 | ADD2 | ADD3 | ADD3-AS1 | ADGRA3 | ADGRE2 | ADGRF3 | ADGRG2 | ADGRL1-AS1 | ADIPOQ-AS1 | ADM5 | ADPGK-AS1 | AEBP1 | AFF1-AS1 | AFG3L1P | AFM | AFP | AFTPH | AGA | AGAP1-IT1 | AGAP11 | AGAP2-AS1 | AGAP4 | AGER | AGL | AGO3 | AGO4 | AGRP | AGT | AGTR1 | AGTR2 | AGXT | AHCY | AHI1 | AHR | AIF1 | AK6P1 | AKAP9 | AKR1C1 | AKR1C2 | AKT1 | AKT3 | ALDH1L1-AS1 | ALG14 | ALK | ALKBH4 | ALMS1-IT1 | ALOX12-AS1 | ALOX15P1 | AMN1 | ANAPC16 | ANAPC1P1 | ANKFN1 | ANKIB1 | ANKRD16 | ANKRD20A12P | ANKRD20A13P | ANKRD20A17P | ANKRD22 | ANKRD24 | ANKRD26P3 | ANKRD49 | ANKRD61 | ANKRD63 | ANKRD66 | ANLN | ANO6 | ANTXR2 | ANTXRL | ANTXRLP1 | ANXA1 | ANXA11 | ANXA13 | ANXA2 | ANXA2P1 | ANXA2P2 | ANXA2P3 | ANXA3 | ANXA4 | ANXA5 | ANXA6 | ANXA7 | AOAH | AP1B1 | AP1G1 | AP1M2 | AP1S1 | AP2A2 | AP2B1 | AP2M1 | AP2S1 | AP3S1 | AP4B1-AS1 | APBB1IP | APCDD1L | APELA | APLNR | APOBEC3A_B | APOBEC3B-AS1 | APOBEC3H | APOC4-APOC2 | APOOP2 | APPAT | APTR | AR | ARAP1-AS2 | ARFRP1 | ARHGAP19-SLIT1 | ARHGAP22-IT1 | ARHGAP26-AS1 | ARHGAP26-IT1 | ARHGAP31-AS1 | ARHGEF26-AS1 | ARHGEF33 | ARHGEF38 | ARHGEF38-IT1 | ARHGEF7-AS1 | ARID2 | ARID3A | ARL14EP | ARL15 | ARL17B | ARL2-SNX15 | ARL4A | ARL4C | ARLNC1 | ARMCX4 | ARMCX5-GPRASP2 | ARMCX6 | ARPC1B | ARPC2 | ARPC3 | ARPC4 | ARPC4-TTLL3 | ARPC5 | ARPIN-AP3S2 | ARRDC3-AS1 | ARX | ASAP1-IT2 | ASNSD1 | ASPN | ASTN2-AS1 | ASXL1 | ATAD2B | ATE1-AS1 | ATF4P4 | ATM | ATN1 | ATP11A-AS1 | ATP13A5-AS1 | ATP2A1-AS1 | ATP5PBP5 | ATP5PO | ATP6AP1 | ATP6AP2 | ATP6V0A1 | ATP6V0B | ATP6V0CP1 | ATP6V0E1P1 | ATP6V1FNB | ATP6V1G2 | ATP6V1G2-DDX39B | ATP7A | ATP7B | ATP8B1-AS1 | ATP9A | ATR | ATRX | B3GALT9 | B3GNT6 | BAALC-AS1 | BABAM2-AS1 | BACE1-AS | BANCR | BAX | BBS12 | BCAP31 | BCAR3-AS1 | BCAS2P2 | BCAS3 | BCL11A | BCL2 | BCL2L1 | BCL2L10 | BCL2L11 | BCL2L2-PABPN1 | BCO1 | BCRP7 | BECN1 | BEST2 | BHLHA15 | BHLHE40-AS1 | BICRA | BIVM | BIVM-ERCC5 | BLACAT1 | BLOC1S1-RDH5 | BLOC1S5-TXNDC5 | BMPER | BMPR1B-DT | BMS1P17 | BMS1P21 | BMS1P7 | BNC2 | BOK-AS1 | BOLA3-DT | BORCS5 | BORCS6 | BORCS7 | BORCS7-ASMT | BPIFB5P | BRAF | BRCA1 | BRINP1 | BRWD1 | BSN-DT | BSPH1 | BSPRY | BTBD1 | BTBD16 | BTG4 | BTN2A3P | BTNL10P | BYSL | C10orf71 | C10orf71-AS1 | C10orf90 | C10orf95-AS1 | C11orf24 | C11orf71 | C11orf91 | C13orf46 | C16orf82 | C16orf95 | C17orf107 | C17orf99 | C18orf54 | C1orf68 | C1QBP | C1QL2 | C1QTNF1-AS1 | C1QTNF3-AMACR | C20orf181 | C21orf58 | C21orf62-AS1 | C21orf91 | C2CD4D | C2CD4D-AS1 | C4B_2 | C4orf46P3 | C5orf52